Trial Profile
Treatment effect of colesevelam for bile acid diarrhoea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2023
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Primary bile acid malabsorption
- Focus Therapeutic Use
- Acronyms SINBAD
- 29 Jul 2022 Status changed from recruiting to completed.
- 26 Dec 2020 Planned number of patients changed from 140 to 170.
- 03 Oct 2018 New trial record